Researchers led by Maike Sander, scientific director of the Max Delbrück Center, have developed a vascularized organoid model ...

Mice genetically engineered to lack the amino acid cysteine, and fed a cysteine-free diet, lost 30 percent of their body weight in a week.

Dystrophic epidermolysis bullosa (DEB) is one of the main subtypes of epidermolysis bullosa, a group of genetic skin ...

National Institutes of Health (NIH) scientists have developed a new surgical technique for implanting multiple tissue grafts ...

Research teams have created a versatile set of gene delivery systems that can reach different neural cell types in the human ...

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...

In April, the Company confirmed that it currently faces no material exposure to newly imposed U.S. tariffs. BioRestorative ...

BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on ...

Detailed price information for Biorestorative Therapies Inc (BRTX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Biorestorative Therapies Inc (BRTX-Q) from The Globe and Mail including charting and trades.

In both cases, the engineered cells adopted unique gene expression profiles – highlighting ... because the microglia are derived from induced pluripotent stem cells, they could possibly be ...